Related Experiment Video
Updated: May 30, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Utilization trends in prostate cancer therapy
Deepak A Kapoor1, Shawn H Zimberg, Lisa M Ohrin
1Integrated Medical Professionals, Melville, New York 11747, USA. dkapoor@imppllc.com
The Journal of Urology
|July 27, 2011
Summary
Treatment for prostate cancer is shifting towards newer technologies like intensity modulated radiation therapy and laparoscopic surgery. Utilization trends for these advanced prostate cancer treatments are consistent across different healthcare settings.
Area of Science:
- Oncology
- Urology
- Medical Economics
Background:
- Prostate cancer management involves various surgical and radiation therapies.
- Understanding treatment trends is crucial for resource allocation and patient care.
- Intensity modulated radiation therapy (IMRT) represents a significant advancement in radiation oncology.
Purpose of the Study:
- To analyze therapeutic trends in prostate cancer management.
- To investigate the influence of service site on intensity modulated radiation therapy (IMRT) utilization.
Main Methods:
- Extracted Medicare Part B data (2006-2008) for prostate cancer treatments.
- Stratified data by year, service type, and radiation therapy site.
- Calculated treatment trends indexed against prostate needle biopsies.
Main Results:
- Overall cancer therapy use increased from 43.8% to 49.0% of beneficiaries.
- Intensity modulated radiation therapy (IMRT) and laparoscopic prostatectomy use rose significantly.
- Open prostatectomy and 3-dimensional conformal radiation therapy use declined.
- IMRT utilization patterns were similar in physician offices and hospitals.
Conclusions:
- Prostate cancer treatment trends favor advanced surgical and radiation technologies.
- Site of service does not significantly impact intensity modulated radiation therapy (IMRT) adoption for prostate cancer.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...